Molecular Mechanisms of Rauvolfia Tetraphylla in Modulating Yap Transcriptional Activity within the Hippo Signalling Pathway to Induce Apoptosis in Breast Cancer Cells A Comprehensive in Silico in Vitro and in Vivo Study
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Rauvolfia tetraphylla, a widely used medicinal plant in traditional medicine,
newlinehas demonstrated therapeutic potential for a variety of diseases. However, its tumorsuppressing
newlineactivity and the role of its phytocompounds against breast cancer remain
newlinelargely unexplored. This study aims to investigate the pharmacological mechanisms of
newlineR. tetraphylla in breast cancer using an integrative approach that encompasses
newlinemolecular docking, molecular dynamics simulations, and experimental validations.
newlineInitial screening via ADME analysis and network pharmacology, which identified key
newlinephytocompounds and their potential molecular targets. Protein-protein interaction (PPI)
newlinenetwork analysis highlighted Yes-associated protein 1 (YAP) as a critical target in
newlinebreast cancer. Molecular docking studies revealed that three compounds ajmaline,
newlinereserpine, and serpentine demonstrated strong binding affinities with YAP, with
newlinedocking scores ranging between -6.5 and -6.7 kcal/mol. To further validate these
newlineinteractions, molecular dynamics simulations were conducted to assess the stability and
newlinedynamics of the compound-protein complexes. In the experimental phase, the
newlinemethanolic extract of R. tetraphylla (RTE) and two isolated compounds, ajmaline
newline(RTC1) and reserpine (RTC2), were tested for their antiproliferative effects against
newlinebreast cancer cell lines (MCF-7 and MDA-MB-231). Among these, RTE and RTC2
newlineexhibited significant cytotoxic activity compared to RTC1. Consequently, further
newlineexperiments focused on RTE and RTC2 to evaluate their impact on proliferation,
newlinemigration, and apoptosis. The results revealed that approximately 80% of treated cells
newlinewere arrested in the G0/G1 phase of the cell cycle, indicating cell cycle inhibition. Dual
newlinestaining assays confirmed the induction of apoptosis
newline